Clinical trial
BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer
NCT04264702 is registered in ClinicalTrials.gov with Natera, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer
- Lead sponsor
- Natera, Inc.
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 24, 2020
- Completion date
- September 30, 2025
- Enrollment
- 1,788 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colon cancer, colorectal cancer